Ipsen Pharma S.A.S.

Research and Markets: Osteoporosis Therapeutics - a Global Market Perspective: the Most Comprehensive Report in Geographic Coverage and Vertical Market Analyses.
Business Wire; 11/26/2009; 954 words; ...on Osteoporosis Therapies * Ipsen Enters into Co-marketing...Osteoporosis Drug from FDA * Merck's New Dosage of FOSAMAX PLUS D Gains FDA Approval * Japanese Pharma Majors Receive Approval for...Switzerland) * Novo Nordisk A/S (Denmark) * Organon * Procter...

Osteoporosis Therapeutics - A Global Market Perspective: The Most Comprehensive Report In Geographic Coverage And Vertical Market Analyses.
M2 Presswire; 11/26/2009; 1050 words; ...on Osteoporosis Therapies - Ipsen Enters into Co-marketing...Osteoporosis Drug from FDA - Merck's New Dosage of FOSAMAX PLUS D Gains FDA Approval - Japanese Pharma Majors Receive Approval for...Switzerland) - Novo Nordisk A/S (Denmark) - Organon - Procter...

Publication No. WO/2009/139855 Published on Nov. 19, Assigned to IPSEN PHARMA for Pharmaceutical Composition (American Inventors)
US Fed News Service, Including US State News; 11/24/2009; 459 words; ...have developed pharmaceutical compositions of somatostatin-dopamine conjugates. The patent has been assigned to IPSEN PHARMA S.A.S., Boulogne-billancourt, France. According to an abstract posted by the World Intellectual Property Organization...

Publication No. WO/2009/138589 Published on Nov. 19, Assigned to Ipsen Pharma for Novel Catalytic System (French, Spanish Inventors)
US Fed News Service, Including US State News; 11/20/2009; 405 words; ...novel catalytic system for the ring-opening (co)polymerization of lactones. The patent has been assigned to Ipsen Pharma S.a.s., Boulogne-Billancourt, France. According to an abstract posted by the World Intellectual Property Organization...

Reportlinker Adds Alzheimer's and Parkinson's Diseases - A Global Update of Market Trends & Opportunities.
PR Newswire; 11/18/2009; 2622 words; ...Johnson 17 Forest 17 Ipsen and UCB 17 Compounds...Market 19 5. PARKINSON'S DISEASE MARKET OVERVIEW...for the Parkinson's disease treatment...32 Eisai Acquires MGI Pharma 32 Eli Lilly Begins...Trial of Alzheimer's Disease Treatment 32...